News

A new study has provided the strongest evidence yet that infection with the Epstein-Barr virus (EBV), which causes glandular fever, may also cause MS.

The results are now in from our 2021 Priorities Survey. With your help, we have understood which of the many different areas of MS research and advocacy are considered the most important by people directly and indirectly affected by MS.

MS Australia President Associate Professor Des Graham presents 'A world without MS: Strategic Plan 2022-2026'.

CEO Rohan Greenland gives an update on the MS Australia activities for the year ahead, focusing on the newly launched five-year strategic plan.

How your support is helping solve the biggest challenges of MS – and giving people like Amy their life back.

The COVID-19 pandemic is ever-evolving; however, we are constantly monitoring developments and providing the latest information on our website. Here we unpack the difference between a primary course of vaccination and boosters.

Researchers have explored the contributions of sun exposure and ultraviolet radiation (UVR) to the risk of children developing MS.

Soliris® (eculizumab), the first TGA-approved medication for NMOSD, has not been recommended for listing on the PBS.

New imaging data shows sustained improvement in disability and increases in myelin density in the brain following an experimental treatment for progressive MS.

CEO Rohan Greenland gives an update on the MS Australia activities for December, focusing on the year ahead for MS Australia.

We look back on the enormous milestones reached in 2021 thanks to the Kiss Goodbye to MS community. Thank you for continuing to accelerate our superpower – MS research.

A recent study from regional NSW is the first to assess if the NDIS package allocated to people with MS matches the level of disability measured by a formal neurological assessment. 

A new study of brain tissue has found that immune cells derived from blood immune cells, attack myelin in the very early stages of MS.

MS Australia National Advocate Erin Brady reflects on International Day of People with Disability in a post-pandemic world.

Our Kiss Goodbye to MS ambassadors say thank you to the fantastic MS community by sharing their very own thank you letters.

MS researchers have investigated whether a naturally occurring molecule, which some DMTs mimic, has the capacity to promote myelin repair.

CEO Rohan Greenland gives an update on the MS Australia activities for November, focusing on MS Australia's 2021 Prime Award nomination.

New research funded by MS Australia has shown how UV light traps immune cells in the lymph nodes, similar to the action of some MS therapies.